Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2022

View Archived Issues

BUB1 biallelic mutations seen to cause microcephaly and developmental delay

STK26 and DPP4 identified as markers tied to severe COVID-19 risk

Therapeutic CAR T cells generated in the body reduce fibrosis in heart disease model in vivo

Pro-IL-12 could treat tumors with reduced toxicity compared to recombinant IL-12

Discovery of VU-6015241, a novel M4 antagonist with promising preclinical profile

Hefei Amvite Pharmaceutical patents histamine H1 receptor antagonists

Shanghai Antengene discloses new ATR kinase inhibitors

Qilu Regor Therapeutics synthesizes new MAP4K1 inhibitors

Shanghai Medicilon presents new S1PR1 modulators

Jiangsu Simcere Medical Equipment divulges new PRMT5 inhibitors

HCW-9218 potentiates antitumor efficacy by reducing TIS-driven proinflammatory phenotype

IMX-110 + anti-PD-1 extend median survival in genetic pancreatic cancer mouse model

INmune Bio collaborates with CUHK to evaluate INKmune in nasopharyngeal cancer

Siga and Bioarchitech collaborate to study Tpoxx with vaccinia-based immunotherapy platform

Tumorad significantly reduces tumor growth and prolongs survival in colorectal cancer model

MAP-tau map of interactions shows more than microtubules

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
DOJ arrests shed light on Medicare skin substitute controversy
BioWorld MedTech
Much has been made of the recent skyrocketing of Medicare spending on skin substitutes, but a new enforcement action by the U.S. Department of Justice might help...